This weekend’s transaction file is about what remains after the headline. A mine sale still needs sovereign approvals, a cross-border bank acquisition now needs a working operating model, and a biotech acquisition is only useful because it arrives with the capital to fund the programme it bought.
Opuwo advances, but approvals still control the cash
Celsius Resources has advanced four conditions for the US$15 million sale of its 95% interest in Namibia’s Opuwo Cobalt-Copper Project to a Chinalco subsidiary. Shareholder approval, environmental clearance, licence renewal and a minority waiver are in place, but approvals in Namibia and China remain outstanding. The transaction is signed; the cash still depends on sovereign completion.
Nedbank’s East African acquisition moves into operation
Nedbank completed its acquisition of a 66% controlling stake in NCBA Group on 19 October. NCBA remains listed on the Nairobi Securities Exchange, with 34% held by public investors. The next transaction is operational: preserve NCBA’s local strengths while connecting the bank to Nedbank’s capital, infrastructure-finance, markets and wealth capabilities across the region.
AFG’s Chad bank entry remains a regulated control process
Chad’s finance ministry announced that Atlantic Financial Group is expected to become majority shareholder in Banque de l’Habitat du Tchad through restructuring and recapitalisation. Final economic terms were not publicly confirmed and COBAC approval remains necessary. The transaction must solve bank repair, new capital, governance and the institution’s commercial mandate together.
Bolt buys a platform and finances the programme together
Bolt Biotherapeutics acquired Prana Therapies on 23 October and announced a concurrent US$120 million private placement to advance PRA-216 and the acquired INSPIRE platform. The acquisition transfers capability; the financing determines whether Bolt can reach the clinical milestones that justify buying it.
Windward opens the IPO process, not the market outcome
Windward Bio filed for a US IPO on 23 October and plans to list on Nasdaq under WWB. The filing opens the process; it does not settle valuation, offer size, investor demand or completion. The company now has to translate clinical science, cash runway and use of proceeds into a public-market case.
What the structure tells us
Africa’s transactions this weekend sit between ownership and execution. NCBA has crossed into a new parent structure, Opuwo has not crossed its final approvals, and BHT is still defining the capital and mandate that control will carry. The status language changes what management must do next.
The global transactions connect capability to capital. Bolt financed the programme it acquired; Windward has only opened the route to public funding. That distinction between announced structure and usable capital is why 0to1 follows the transaction rather than only the headline.
transactions · mining · banking · control transaction · post-merger integration · recapitalisation · biotechnology · IPO